NEOLEUKIN THERAPEUTICS INC (NLTX) Stock News

Neoleukin Therapeutics announces 1-for-4 reverse stock split (NASDAQ:NLTX)

Neoleukin Therapeutics approves a 1-for-4 reverse stock split to comply with Nasdaq's minimum bid price requirement.

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has...

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Mentions: DYAI ICU IPHA KRMD ...

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket

Gainers

Mentions: SSU ISPO MKUL RGP ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning!

Mentions: ORTX WNW MKUL GROM ...

Neoleukin Therapeutics announces 1-for-5 reverse stock split (NASDAQ:NLTX)

Neoleukin Therapeutics implements reverse stock split to comply with Nasdaq's minimum bid price requirement. Stock trading begins on September 25.

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that...

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: HCCI CCF SCU

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: PRDS CCF SCU

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CCF, NLTX, SCU

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: AMNB CCF SCU

Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

Mentions: PRDS AMNB SCU

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: AJX DEN FREQ

NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, NLTX, AJX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: SCU PRDS AJX

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)

Mentions: SCU PRDS AJX RITM

Shareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene

/PRNewswire/ -- Ademi LLP is investigating Neoleukin (Nasdaq: NLTX) for possible breaches of fiduciary duty and other violations of law in its private...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQ

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mentions: DEN FREQ

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)

Mentions: PRDS KLR AJX

NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders

Neoleukin jumps 7% on Neurogene merger (NASDAQ:NLTX)

Clinical-stage company, Neurogene and Neoleukin Therapeutics (NLTX) to combine the companies in an all-stock transaction

Neurogene and Neoleukin Announce Definitive Merger Agreement

Proposed merger to create Nasdaq-listed biotech company focused on advancing Neurogene’s differentiated portfolio of genetic medicines for complex...

Neurogene and Neoleukin Announce Definitive Merger Agreement

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning!

Mentions: TTC BPTS BCAN ATXI ...

Neoleukin Therapeutics to cut 70% workforce, CEO steps down (NASDAQ:NLTX)

Biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, Neoleukin Therapeutics (NLTX) to reduce workforce by ~70%.The company...

Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated...

Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting

Targeted, precision-tuned agonist of IL-2 receptor selectively expands regulatory T cells...